- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06694103
The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination
The Effect of Reverse Kangaroo Care Position and ROP Position on Pain During Retinopathy Examination in Premature Infants
The goal of this randomized controlled trial is to determine the effect of reverse kangaroo care position and ROP (Retinopathy of Prematurity) position applied during ROP examination in premature infants on pain. The main questions it aims to answer are as follows:
- Is the reverse kangaroo care position effective in reducing the pain of premature infants during the ROP examination?
- Is the reverse kangaroo care position more effective in reducing the pain of premature infants compared to the ROP position during the ROP examination?
Researchers will determine the effect of reverse kangaroo care position and ROP position applied during premature retinopathy examination in premature infants with a gestational age of less than 34 weeks on pain in infants.
- The infants of parents who volunteer to participate in the study will be divided into two groups as Reverse Kangaroo Care Position group and ROP Position group according to randomization.
- From the infants whose pupils are sufficiently mydriasis and are taken to the examination table, premature infants in the ROP Position group will be given ROP position together with the nurse and the parent.
- Premature infants in the Reverse Kangaroo Care Position group will be given reverse kangaroo care position.
- Video recording will be made during the given positions.
- The effects of the applied positions on pain will be determined as a result of the measured parameters before, during and after the examination.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- 84 premature infants that meet the sample criteria will be determined.
- Randomization will be performed and premature babies will be assigned to the Reverse Kangaroo Care Position (Group 1) and Rope Position (Group 2) groups.
- The purpose of the study will be explained to the mother by meeting her and written consent will be obtained.
- The Premature Identification Form, which includes information about the infant, will be filled out.
According to the groups to which the premature infants who were randomized were assigned;
One minute before the examination;
- The infants will be placed on the examination table and one drop of %0.5 alcaine (proparacaine HCl) topical anesthetic eye drops will be applied to both eyes of the premature infantss assigned to both groups by the neonatal intensive care nurse.
- The pulse oximetry probe will be attached to the infants' right feet and monitored.
- The infants will be positioned according to the group they are assigned to.
- Video recording will be started one minute before the examination and will continue until 1 minute after the examination.
- In order to evaluate the SPO2, KTA, PIPP-R values of all groups at the 15th second before the examination, the infant will be recorded on video for one minute.
During the Examination; In the Reverse Kangaroo Care Position Group;
- While the reverse kangaroo care position applied to the infants is maintained, the speculum is placed on the eye by the ophthalmologist and the video recording will continue throughout the examination from the moment the examination begins
- The SPO2, KTA, PIPP-R in the 1st minute of the examination will be recorded for evaluation
In the ROP Position Group;
- While the ROP position applied to the babies is maintained, the speculum is placed on the eye by the ophthalmologist and the video recording will continue throughout the examination from the moment the examination begins
- The SPO2, KTA, PIPP-R in the 1st minute of the examination will be recorded for evaluation
At the end of the examination;
- After the completion of both eye examinations, the video recording will continue for 1 more minute while the positions of the babies whose monitoring continues are maintained
- The video recording will end 1 minute after the examination ends
- The infant's SPO2, KTA, values, PIPP-R pain score will be evaluated and recorded
- . The aim is to record the infant's SPO2 and KTA values at 30 seconds so that the PIPP-R pain score can be evaluated later.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sinem Başdemir, Research Assistant
- Phone Number: +905550074974
- Email: sinem.basdemir@bakircay.edu.tr
Study Contact Backup
- Name: Sayime Aydın Eroğlu, Associate Professor
- Phone Number: +905338180576
- Email: sayime.aydin@gmail.com
Study Locations
-
-
Menemen
-
İ̇zmi̇r, Menemen, Turkey, 35610
- Recruiting
- Izmır Provincial Health Directorate Bakircay University Cigli Regional Educational Hospital
-
Contact:
- Sinem Başdemir, Research Assistant
- Phone Number: +905550074974
- Email: sinem.basdemir@bakircay.edu.tr
-
Contact:
- Hatice Bal Yılmaz, Prof. Dr.
- Phone Number: +905321323756
- Email: hatice.bal.yilmaz@ege.edu.tr
-
Sub-Investigator:
- Sinem Başdemir, Research Assistant
-
Principal Investigator:
- Hatice Bal Yılmaz, Prof. Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Gestational age <34 weeks,
- Birth weight ≤ 2500 grams,
- No painful interventions at least 1 hour before the ROP examination,
- Fed at least 1 hour before the ROP examination,
- Premature infants whose parents consented to participate in the study.
Exclusion Criteria:
- Having a condition that prevents pain assessment (intracranial hemorrhage, neuromotor developmental delay etc.)
- Any congenital anomaly (eye, neurological, etc.),
- Have a diagnosed hearing problem,
- A different painful procedure was performed at least one hour before the ROP examination,
- Administration of an analgesic/sedative medication before the examination,
- Premature infants whose parents did not consent to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Reverse Kangaroo Care Position Group
The advantages of kangaroo care will be utilised in the ROP examination.
By reversing the position of the baby's face to the mother's breast, a change in the traditional kangaroo care posture will be applied, called the reverse kangaroo care position.
Premature infants will be placed on the examination table for ROP examination and the infants' clothes other than diapers will be removed.
Mothers will lie on the examination table by removing their upper clothes and their infants will be positioned in the inverted kangaroo care position, with the infant's back resting between the mother's bare chest.
The privacy of the mother and the infant will be ensured and the infant will be able to smell the mother's scent with a piece of clothing taken off by the mother.
|
|
|
Experimental: ROP Position Group
The position is given while the premature infant is in the supine position with the presence of two people (mother and nurse).
It is performed in two stages by positioning the lower and upper extremities of the premature infant.
The feet and legs are in the lower extremities, and the arms and head are in the upper extremities.
During the examination, the premature infant's head is in slight hyperextension so that the retinal maneuvers applied by the ophthalmologist can be easily performed.
The nurse places the infant's own palms on the temporal region and supports the head by holding it with her hands, while the mother supports the infant by bringing the infant's legs together and pushing it towards her abdomen.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Premature Introductory Information Form:
Time Frame: Pre-intervention
|
It was prepared by the researcher to determine the characteristics of the premature babies participating in the study.
It consists of seven questions including the baby's gender, gestational week, birth weight, postnatal week, delivery method, birth head circumference and height measurement.
|
Pre-intervention
|
|
Premature Infant Follow-up Form
Time Frame: 15th minute before the examination; 1st minute during the examination, 30 seconds after the examination
|
It consists of fields including the premature infant's heart rate, oxygen saturation values and PIPP-R score at the 15th second before the examination, the 1st minute during the examination and the 30 seconds after the examination.
|
15th minute before the examination; 1st minute during the examination, 30 seconds after the examination
|
|
Premature Infant Pain Profile Scale-Revised Form (PIPP-R)
Time Frame: 15th second before the examination; 1st minute during the examination, 30 seconds after the examination
|
It is a Likert-type scale.
In the scoring of the scale, items related to physiological and behavioral indicators are scored as 0, 1, 2 and 3 points for each variable.
Items related to contextual indicators (behavioral status and gestational age) are scored as 3, 2, 1 and 0 points at the beginning of the pain assessment (before contact with the baby).
According to PIPP-R, the infant's pain is evaluated based on the total score.
In scoring the PIPP-R, behavioral and physiological indicators are scored at the end of the scale.
Accordingly, if the infant receives a zero score (subtotal) from the general physiological and behavioral indicators, the contextual indicators are not scored.
If the infant receives a score above zero from the initial parameters, the total score is obtained by including the contextual indicators in the scoring.
The highest score of the PIPP-R is 21 for preterm infants and 18 for term infants (Stevens et al., 2014).
|
15th second before the examination; 1st minute during the examination, 30 seconds after the examination
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hatice Bal Yılmaz, Prof. Dr., Ege University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EU-HEM-SB-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinopathy of Prematurity (ROP)
-
Vanderbilt University Medical CenterNational Institutes of Health (NIH)RecruitingRetinopathy of Prematurity (ROP) | ROP ExaminationUnited States
-
BayerRegeneron PharmaceuticalsCompletedRetinopathy of Prematurity (ROP)Spain, Taiwan, Singapore, Malaysia, Japan, Israel, Bulgaria, Argentina, Czechia, Greece, Netherlands, Slovakia, United Kingdom, Sweden, Hungary, Romania, Italy, Ukraine, South Korea, Portugal, Turkey (Türkiye), Brazil, Belgium, Russia
-
University Hospital FreiburgWithdrawn
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedRetinopathy of Prematurity (ROP)United States
-
Novartis PharmaceuticalsCompletedRetinopathy of Prematurity (ROP)United States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Hungary, India, Italy, Japan, Malaysia, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United Kingdom, Lithuania, Estonia
-
ShireCompletedRetinopathy of Prematurity (ROP)United States, Italy, Netherlands, Poland, Sweden, United Kingdom
-
BayerRegeneron PharmaceuticalsCompletedAflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy (FIREFLEYE)Retinopathy of Prematurity (ROP)Spain, Singapore, Hong Kong, Korea, Republic of, Malaysia, Japan, Taiwan, Sweden, Portugal, Belgium, Argentina, Bulgaria, Italy, Austria, Brazil, Czechia, Greece, Hungary, Israel, Netherlands, Poland, Romania, Russian Federation, Slov... and more
-
University Hospital FreiburgCompletedRetinopathy of Prematurity (ROP)Germany
-
ShireCompletedRetinopathy of Prematurity (ROP)United States, Italy, Netherlands, United Kingdom, Sweden, Poland
-
Alaska Blind Child DiscoveryCompleted
Clinical Trials on Reverse Kangaroo Care Position
-
Maltepe UniversityIstanbul University - CerrahpasaCompletedHeel Lancing | Skin to Skin Contact | Heel Lance Procedures | Kangaroo Mother CareTurkey (Türkiye)
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeyCompletedCerebral Oxygenation | Premature | Facilitated Tucking | Kangaroo CareTurkey
-
Professor Fernando Figueira Integral Medicine InstituteConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownKangaroo Mother Care MethodBrazil
-
Professor Fernando Figueira Integral Medicine InstituteUnknown
-
Tarsus UniversityNot yet recruitingNewborn CareTurkey (Türkiye)
-
Kirsehir Ahi Evran UniversitesiNot yet recruitingThe Gestational Age of the Newborn is Between 28-37 Weeks | Stable Health Status of the Newborn | Mothers' Willingness to Participate in the Study
-
Selcuk UniversityCompletedPremature InfantsTurkey
-
Meir Medical CenterCompletedPreTerm Birth | Stress ReactionIsrael
-
Fatih UniversityUnknownImmaturity | Oral Intolerance | Postnatal AdaptationTurkey
-
Zeynep Büşra GÜÇLÜSelcuk UniversityActive, not recruitingPreterm Birth | Nurse's Role | FathersTurkey